Xtant Medical Holdings, Inc. Stock: price and insider trades · United States

Xtant Medical Holdings, Inc. (ticker: XTNT) is a U.S.-based medical technology company listed on NYSE American in the United States. Headquartered in Belgrade, Montana, the company develops, manufactures, and commercializes a portfolio centered on regenerative biologics and spinal implant systems, with an expanding presence in selected wound-care applications. Its products are used by orthopedic surgeons, spine surgeons, and other specialists treating spinal, musculoskeletal, and tissue-healing conditions. The business is positioned as an integrated supplier that can provide both biologic grafting solutions and fixation systems, which is attractive to hospitals, ambulatory surgery centers, and distributor channels seeking a broad procedural offering from a single vendor.

Xtant’s roots trace back to its tissue-bank heritage and its close connection to Montana State University’s Center for Biofilm Engineering. That background remains important because it underpins the company’s emphasis on donor tissue processing, proprietary manufacturing, quality control, and traceability. Over time, Xtant has evolved into a more vertically integrated orthobiologics platform, with processing capabilities and commercialization infrastructure designed to support a broad range of regenerative products. Its biologics portfolio includes solutions for spinal fusion and bone regeneration, while its spinal implant line spans cervical, thoracolumbar, and interbody systems designed to work alongside its graft products. The company also markets wound-care-related biologic offerings, including more recently introduced amniotic products.